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ABSTRACT
Objective: To construct confidence intervals for HIV
prevalence in countries with generalised epidemics.
Methods: In the Bayesian melding approach, a sample of
country-specific epidemic curves describing HIV preva-
lence over time is derived based on time series of
antenatal clinic prevalence data and general information
on the parameters that describe the HIV epidemic. The
prevalence trends at antenatal clinics are calibrated to
population-based HIV prevalence estimates from national
surveys. For countries without population based esti-
mates, a general calibration method is developed. Based
on the sample of calibrated epidemic curves, we derive
annual 95% confidence intervals for HIV prevalence. The
curve that best represents the data at antenatal clinics
and population-based surveys, as well as general
information about the epidemic, is chosen to represent
the best estimates and predictions.
Results: We present results for urban areas in Haiti and
Namibia to illustrate the estimates and confidence
intervals that are derived with the methodology.
In 2003, UNAIDS included information on uncer-
tainty in its estimates and projections by calculat-
ing and presenting plausibility bounds. These
bounds were derived by combining the results of
a bootstrap method with expert opinion regarding
the range of possible epidemic curves, as explained
by Grassly et al.
1 The method was further devel-
oped by Morgan et al.
2 The results of the method,
the plausibility bounds, are not formal statistical
confidence intervals. Alkema et al
3 proposed using
Bayesian melding for uncertainty assessment in the
model in the Estimation and Projection Package
(EPP), the package used by UNAIDS and country
officials for prevalence estimation and prediction.
Bayesian melding provides a way of including
expert opinion while still giving formal statistical
confidence intervals. It is a method for assessing
uncertainty about the inputs and outputs of a
deterministic model, such as the EPP model.
Bayesian melding was first developed to estimate
the rate of increase of whale populations,
45and
was successfully applied to policymaking in that
context. When applying this approach to the EPP
model, it gives a ‘‘best’’ trajectory of HIV
prevalence over time, as well as the uncertainty
in the estimates and projections in the form of a set
of possible epidemic curves. These curves reflect
the uncertainty about the past and future and are
based on the (imperfect) information that is
available about the model’s inputs and outputs.
In 2006 the UNAIDS Reference Group on
Estimates, Modelling and Projections recommend-
ed the use of Bayesian melding for uncertainty
assessment in EPP.
6 The application of Bayesian
melding to the EPP model is discussed in detail by
Alkema et al.
3 Brown et al
7 discuss the implementa-
tion details. In this paper we summarise the
approach in a less technical way in the Methods
section and discuss the recent changes based on
recommendations by the UNAIDS reference group:
the prior distributions on the input parameters and
the calibration of prevalence curves based on ANC
prevalence to the outcomes of population-based
surveys. We give results for Haiti and Namibia and
end with a discussion of the method.
METHODS
Bayesian melding for the Estimation and Projection
Package
In Bayesian melding, ‘‘melding’’ refers to combin-
ing (melding) information about the inputs and
outputs of a deterministic model, such as the
model in EPP for generalised epidemics.
8 In the EPP
model, the population of 15–49-year-olds is divided
into three groups, a not-at-risk group, an at-risk
group and an infected group. Three differential
equations describe the changes in those groups over
time, and thus in prevalence over time. Four
parameters determine the shape of the epidemic
curve: r, which is the growth rate of the epidemic,
f0, the fraction of population initially at risk, t0 the
start year of the epidemic (in which a fraction of
the population that is initially at risk gets infected)
and w, a parameter that modulates recruitment to
the at-risk population. Information about the
inputs and outputs in the EPP model is given by
expert knowledge about the input parameters and
upper bounds on prevalence in certain years, and
prevalence data.
‘‘Bayesian’’ refers to Bayesian inference, which
starts by quantifying prior beliefs (expert knowl-
edge) about the true value of a quantity of interest.
For example, in HIV estimation using EPP, there
could be a consensus that the generalised epidemic
started no sooner than 1970 and no later than
1990. The upper and lower bounds on the start
year of the epidemic serve as boundaries on any
projections that would then be developed. In
Bayesian inference, prior beliefs are represented
by probability distributions—for example, the start
year of the epidemic could have a uniform
distribution on the interval between the upper
and lower bounds. Likewise, prior distributions can
be determined for the other three parameters in the
epidemic curve fit, as well as for the output of the
EPP model, prevalence over time. For example,
there could be a consensus that prevalence in 1980
was no higher than 5%.
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generate a set of possible epidemic curves (curves that are based
on the EPP parameters and satisfy the constraints imposed on
prevalence). The prior distributions are then updated based on
the observed outcomes of comparing these curves with the
observed data. For HIV prevalence estimates with the EPP
model, HIV prevalence is observed at antenatal clinics, and for
many countries population surveys are available as well. Data
and information on measurement errors are used to calculate a
measure of the so-called ‘‘likelihood’’: an epidemic curve which
is similar to the level and trend in observed prevalence has a high
likelihood of representing true prevalence.
Combining prior distributions with likelihood (updating prior
beliefs) gives the ‘‘posterior’’ distribution of the quantity of
interest. Melding the prior distributions on inputs and output
with the likelihood on output gives posterior distributions on
inputs as well as outputs—for example, the posterior distribu-
tion of past and future prevalence.
The Bayesian melding approach for EPP produces a sample
from the posterior distributions on inputs and outputs. All the
information that is needed can be derived from this sample. We
will discuss how the best prediction is calculated from the
posterior sample of prevalence curves, as well as how the
confidence intervals (or so-called ‘‘uncertainty bounds’’) are
constructed.
Constructing a sample of prevalence curves
We now describe how to get a sample of prevalence curves
based on data from antenatal clinics (ANC). For many
countries, these datasets are the main source of the times series
of prevalence data that are needed to estimate the trend in HIV
prevalence. Nationally representative population surveys,
including the demographic and health surveys (DHS) and
AIDS indicator surveys (AIS), are available for an increasing
number of countries.
9 These data are used to calibrate the ANC
prevalence, as discussed below.
The sample from the posterior distribution of HIV prevalence
curves is drawn using the sampling importance resample (SIR)
algorithm
10 11 as follows:
c Sample a large number of different combinations of the
input parameters r, f0, t0 and w from their prior distributions.
To draw one value from the joint prior distribution of the
four input parameters, we proceed as follows. For each of
the four parameters, we randomly sample one value from
that parameter’s prior distribution. Because the four
parameters are statistically independent in the prior
distribution, this is a draw from the joint prior distribution.
c For each combination of the input parameters, run the EPP
model to produce the corresponding epidemic curve.
c Each curve is compared to HIV prevalence data from
antenatal clinics and assigned a weight based on the
likelihood of the curve (how well it fits the data) and the
previous assumptions on prevalence. The calculation of
likelihoods and weights is discussed in detail by Alkema et
al.
3 For example, if the epidemic curve, as generated by the
various combinations of input parameters, is very different
from the observed rates, that curve will get a low or zero
weight. If the curve resembles the data reasonably well, it
will get a high weight. If the curve falls outside any user
established previous limitations on prevalence (for example,
if the expert user specified prevalence in 1999 is less than 5%
and the curve being compared has a prevalence of 9%), its
weight is set to zero.
c The epidemic curves as well as their input parameters get
resampled, based on these weights. The probability of
resampling is proportional to the weight that has been
assigned to that curve.
The result is a sample from the posterior distribution of
prevalence, in the form of a set of prevalence curves. The
number of sets of input parameters that are sampled in step 1
should be large enough such that they cover the input space and
a reasonable number of unique curves get selected in the last
step—for example, at least 100 curves. We found 200 000 sets of
inputs to work well for most countries to cover the input space.
A much smaller number is needed in the resample step
5—for
example, 3000 curves, to get a sample from the posterior. These
sample sizes are rough guidelines, and depend on the dataset
that is being used to analyse HIV prevalence over time.
Prior distributions
Prior distributions on the four input parameters to the EPP
model are specified using expert knowledge. They should be
broad enough so as not to exclude values that are supported by
the data (that is, that have high likelihood) unless there is strong
knowledge that excluding some values is appropriate. In the EPP
2007 computer program, default prior distributions are given for
each of the four input parameters. The prior distribution for the
fraction initially at risk, f0, is uniform between 0 and 1, and the
start year of the epidemic, t0, is discrete uniform on {1970, …,
1990}. If the default limits on these distributions are too
constraining, users can change them to ones that are appro-
priate for their own country’s situation—for example, in many
Asian countries, a more reasonable range of start years might be
1980 to 2000.
Values of the rate of increase, r, as used in the country
projections by UNAIDS in 2005, are shown in figure 1A. Based
on this, the default prior distribution for r in EPP 2007 was set to
be uniform on the log scale between 0.5 and 150; its density
function is shown in the figure.
Figure 1B shows the estimates of the behavioral response w
from 2005 (excluding a few very large values, for easier
visualisation). The default prior distribution chosen for the
behavioural response w is drawn in the same figure and is given
by:
w,Logistic(100,50) (1)
Figure 1 Histogram of UNAIDS 2005 estimates for (A) r with density of
exp(U[log(0.5), log(150)]) in red and (B) w with density of
logistic(100,50) in red.
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around 100. This is broad enough to cover the range of the
previous estimates, and also reflects the expectation that the
behavioural response parameter is unlikely to be highly
negative.
EPP also allows the user to specify upper or lower bounds
on prevalence in certain years—for example, restricting pre-
valence in 1980 to be smaller than 1% to exclude unrealistic
epidemic curves that peak around that year at high prevalence
levels.
Calibrating ANC prevalence curves
ANC data are used for estimating the trend in HIV prevalence
as for many countries these datasets are the main source of
times series of prevalence data. Because of the difference
between ANC prevalence and population prevalence as mea-
sured by population-based surveys as discussed by Garcia-
Calleja et al
9 and Gouws,
12 calibration of the prevalence curves
based on, and thus representing, ANC prevalence is needed.
This section discusses the calibration of HIV prevalence for
countries in which one or more population surveys have been
conducted, and the calibration method for countries without
population surveys, based on observed differences between
ANC and population prevalence in other countries.
Countries with population-based survey(s)
For countries with one population estimate, a calibration
constant is calculated such that median posterior prevalence
in the year of the survey as given by the Bayesian melding
procedure based on ANC data will be rescaled at the population
estimate. As in the paper by Alkema et al,
3 differences in
prevalence levels will be modelled on the probit scale. This scale
is chosen such that differences between prevalence levels do not
depend on the level itself (the probit transformation approxi-
mately stabilises the variance). The calibration constant, the
difference between population prevalence and ANC prevalence,
is constant over time on the probit scale, such that the influence
of the calibration constant decreases for lower prevalence. We
define probit transformed observed HIV prevalence as measured
in population survey in year t as:
Wpop,t=W
21(xpop,t) (2)
where W(?) is the standard normal cumulative distribution
function and
In equation 3, Ypop,t is the number of HIV-positives in the
DHS sample in year t and Npop,t is the sample size of the
population survey. The constants 1/2 and 1 in equation 3 are
included to avoid problems with zeros. We denote the probit
transformed curves representing ANC prevalence by VANC and
the transformed median estimate in year t by V ˆ
ANC,t. The
calibration constant for the DHS survey in year t is denoted by ct
and given by:
ct=W pop,t–V ˆANC,t (4)
For countries with one survey, the final calibration constant
is c=c t, and is added to the trajectories of antenatal clinic
prevalence to get the calibrated population prevalence:
where Vpop is a sampled calibrated epidemic curve on the probit
scale, and r is a sampled trajectory of HIV prevalence
representative for the overall population. Note that calibration
is done separately for urban and rural areas.
In order to take into account the uncertainty in the
population estimate the calibrated curves need to be resampled,
with weights proportional to the population survey likelihood,
to incorporate the likelihood of the population estimates in the
posterior sample of prevalence curves. As for the antenatal clinic
data given by Alkema et al,
3 we derive the likelihood for DHS
data by assuming that the sampling error is normally
distributed on the probit scale:
Vpop,t|Wpop,t,N(Wpop,t, Var(Wpop,t)) (7)
The variance of the population estimate is based on the
binomial variance in the sample, multiplied by the design effect
to take into account the cluster sampling procedure. The design
effect for a cluster design is the ratio of the variance for that
design to the variance calculated from a simple random sample
of the same size. In EPP 2007 the default value for the design
effect is 2, according to UNAIDS guidelines for measuring
prevalence in population-based surveys.
13 With design effect d,
the variance of the population estimate on the probit scale is
approximately equal to:
where rpop,t is the true population prevalence rate. Estimating
rpop,t by xpop,t gives an estimate of the variance on the probit
scale. The likelihood of the population data given a calibrated
epidemic curve can now be determined using equation 7. An
example of the calibration is given in the Results section for
Haiti.
For countries with more than one survey, the calibration
constant c is given by the mean of each of the survey-specific
calibration constants. Using weights in the resample step that
are proportional to the product of the likelihoods of the
population surveys results in higher weights for curves that
best resemble the trend as given by the population estimates,
thus confidence intervals that incorporate the trends as given by
the population estimates.
Countries without a population-based survey
EPP allows ANC prevalence estimates for countries without
population-based estimates to be adjusted based on the biases
revealed by population surveys in other countries. We assume
that there is an overall bias that gives the difference between
ANC and population surveys. This bias is unknown, because of
the measurement errors in both the ANC and the population
estimates. The mean bias and its standard error are estimated
from the data from countries with population surveys,
separately for urban and rural areas. These estimates are used
to adjust ANC prevalence in countries without population
prevalence estimates.
(3)
(8)
(5)
(6)
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estimates are used to calculate calibration constants on the
probit scale. The distribution of the calibration constant is
based on the observed ANC bias in 17 countries in sub-Saharan
Africa (Burkina Faso, Burundi, Cameroon, Chad, Ghana,
Guinea, Ethiopia, Kenya, Lesotho, Malawi, Mali, Niger,
Rwanda, Sierra Leone, Tanzania, Uganda and Zambia). The
adjustment for rural areas is bigger than for urban areas, so we
derive the distribution of the calibration constant for those two
subpopulations separately. On the probit scale the mean
calibration constant (difference between ANC and DHS
prevalence) for urban areas is 0.11 with standard error 0.04,
for rural areas 0.17 with standard error 0.05.
To construct calibrated prevalence curves that are represen-
tative for the overall population in urban areas, a calibration
constant curban is sampled and added to VANC:
curban,N(0.11,0.04
2) (9)
r=W(Vpop) (11)
where VANC is a sampled trajectory of ANC prevalence on the
probit scale, Vpop is the corresponding calibrated epidemic curve
on the probit scale and r is the resulting sampled trajectory of
HIV prevalence for the overall population, in this case the
population living in urban areas. The adjustment for rural
epidemics is done similarly, with:
crural,N(0.17,0.05
2) (12)
Table 1 summarises the effect of the calibration when ANC
prevalence is 5%, 10%, 15% and 20%. For example, if ANC
prevalence is 15% in urban areas, urban population prevalence is
estimated as 12.6% (95% confidence interval (CI) 11.2% to
14.1%). The downward adjustment is larger for rural preva-
lence—for example, if ANC prevalence is 15%, the adjusted
prevalence in rural areas is 11.3% (95% CI 9.6% to 13.3%).
Figure 2 shows the ratio of adjusted (calibrated) prevalence to
ANC prevalence for ANC prevalence ranging from 0 to 30%.
The observed ratios of DHS surveys to ANC prevalence are
shown in the same figure. The results of this calibration method
are illustrated for urban areas in Namibia in the Results section.
Best estimate and confidence intervals
Based on the (calibrated) sample of curves from the posterior
distribution of HIV prevalence curves, a 95% confidence interval
for prevalence in a given year is given by the lower 2.5th and the
upper 97.5th percentiles of the prevalences for that year within
the sample. The ‘‘best’’ estimates are given by the trajectory
that is most likely to represent prevalence over time, given prior
distributions and data. This maximum a posteriori (MAP)
trajectory is the one with the highest posterior density,
proportional to the product of the prior distributions on the
inputs of the curve, the prior distributions on outputs and the
likelihood of the data. For countries without a population
estimate, the best calibrated prediction is given by the MAP
curve as derived for ANC data, with the mean calibration
constant added to it. For countries with one or more population
estimates, the maximum a posteriori curve is given by the
calibrated curve with the maximum product of input priors,
ANC likelihood and population-based likelihood.
Epidemics are fitted separately for urban and rural areas,
giving so-called ‘‘sub-epidemics’’ within one country. For
deriving nationally representative estimates and projections,
sub-epidemics are combined by sampling trajectories from each
sub-epidemic, weighting each trajectory by population size in
each year and adding them up. Confidence intervals are then
constructed based on the nationally representative sample of
trajectories. Best estimates for national prevalence are given by a
weighted average of the maximum a posteriori estimates of the
sub-epidemics, with weights given by population size.
RESULTS
In this section we will present the results of the Bayesian
melding procedure for urban areas in Haiti and Namibia. Note
that the estimates and predictions as derived here are illustrative
and are not the official estimates, as our analysis might not
include all the information available.
Adult HIV prevalence in the Caribbean is estimated at 1.0%
(95% CI 0.9% to 1.2%) in 2007.
14 Prevalence in this region is
highest in the Dominican Republic and Haiti. In figure 3A, HIV
prevalence data for urban areas in Haiti are given by the
coloured lines for 17 antenatal clinics (data taken from Gaillard
et al
15). Sample sizes for each clinic range from 14 to 393 women,
and observed prevalence in 2006–7 ranges from 0% to 12.2%.
The light grey curves in the plot are a sample from the posterior
distribution of the ANC prevalence curves, based on the default
priors on the input parameters, and restricting prevalence in
1980 to be smaller than 1%. The red curve gives the best
estimates (MAP curve) and the broken lines show the year-
specific 95% confidence and prediction intervals. Based on
antenatal clinic data, the posterior median of prevalence is 5.3%
for 2007 (95% CI 4.3% to 6.7%).
Figure 2 Ratio of adjusted antenatal clinics (ANC) prevalence to ANC
prevalence for countries without a population survey for (A) urban and
(B) rural areas. The grey line is the identity line representing no
adjustment. The solid black lines are the adjustments of ANC prevalence
based on the observed mean adjustments (on the probit scale) in other
countries. The broken lines give the 95% CI for the ratio of estimated
prevalence to ANC prevalence after adjustment. The dots are the
observed outcomes of the ratio of DHS surveys to estimated ANC
prevalence.
Table 1 Adjustments of ANC prevalence for urban and rural areas with
95% confidence intervals for the adjustment
ANC prevalence
(%)
Urban adjusted
prevalence (%)
Rural adjusted
prevalence (%)
5 4.0 (3.4 to 4.6) 3.5 (2.8 to 4.3)
10 8.2 (7.2 to 9.3) 7.3 (6.0 to 8.7)
15 12.6 (11.2 to 14.1) 11.3 (9.6 to 13.3)
20 17.1 (15.4 to 18.9) 15.5 (13.3 to 17.9)
(10)
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Haiti. For urban areas, HIV prevalence was estimated to be 2.3%
(with sample size 4382, design effect set to 2). In figure 3A and
3B the DHS estimate is shown by the red diamond. In figure 3B,
this estimate is used to calibrate the trajectories as given by the
ANC data. In this plot, each of the light grey curves represents
calibrated prevalence over time, with 95% confidence intervals
(broken lines) and best estimate as given by the MAP curve
(red). The calibration based on the DHS estimate gives a
significant reduction in estimated prevalence level and uncer-
tainty. Based on ANC data and the DHS estimate, the posterior
median of prevalence is 2.3% for 2007 (95% CI 1.9% to 2.8%).
Namibia
Namibia is one of the countries in southern Africa with high
HIV prevalence levels. Figure 4 shows data from 12 antenatal
clinics in urban areas (Windhoek Central Hospital,
Grootfontein, Oshakati, Katutura, Rundu, Otjiwarongo,
Tsumeb, Rehoboth, Gobabis, Mariental, Katima Mulilo and
Walvisbay, data taken from the epidemiological fact sheets on
HIV/AIDS and sexually transmitted infections 2006 at http://
www.who.int/globalatlas/predefinedReports/EFS2006/index.asp
and Ministry of Health and Social Services Namibia
16). Based on
the antenatal clinic data, median prevalence in 2007 is estimated
at 16.9% (95% CI 13.2% to 22.1%).
Namibia has no population survey to calibrate the ANC
prevalence curves. We use the general calibration method as
described in the previous section. The results are shown in
figure 4B. After calibrating the ANC curves, median prevalence
in 2007 is estimated at 14.6% (95% CI 10.8% to 19.7%). Note
the uncertainty in past estimates in HIV prevalence: the widths
of the confidence intervals are approximately 10% from 1999
until 2006.
DISCUSSION
In this article we have described the Bayesian melding approach
to assessing uncertainty in HIV prevalence estimates as given by
the model in the Estimation and Projection Package. Using the
Bayesian melding procedure, prevalence over time is described
by a sample of epidemic trajectories, which are chosen based on
all available information about input parameters of the model
and prevalence data. Uncertainty about prevalence is given by
year-specific 95% confidence intervals.
The Bayesian melding approach allows users of EPP to get a
better insight into HIV prevalence trends, specifically in the
range of epidemic curves describing the situation in their area of
interest and the uncertainty bounds associated with the best
estimates. Compared to the previous approach for uncertainty
assessment in EPP,
2 this approach produces statistical con-
fidence intervals and allows for incorporating expert informa-
tion on model input and prevalence outcomes.
The number of curves needed to get an appropriate sample of
the the posterior distribution of prevalence curves in the
sampling importance resampling method depends on the
dataset that is being analysed. More curves will give a more
accurate result. The optimal number of curves to generate and
resample depends on the pay-off of longer computations versus
increased accuracy. In this paper we give some rough guidelines
for sample sizes. In future work we will explore more efficient
sampling algorithms and specify stopping rules.
The trend in prevalence over time is derived from what has
been observed at antenatal clinics and calibrated to represent
prevalence in the overall population based on population-based
surveys. In the current calibration of HIV prevalence curves to
population-based estimates, the latter estimates are taken to be
unbiased estimates of population prevalence. Calibrating pre-
valence in urban areas in Haiti based on the DHS estimate of
Figure 3 Bayesian melding for
estimating and projecting HIV prevalence
(on the Y-axis) in urban areas of Haiti (A)
based on antenatal clinic data only, and
(B) based on antenatal clinic data and the
2006 DHS survey. The coloured lines with
symbols show the raw antenatal clinic
prevalence rates and the red diamond
shows the DHS estimate. The light grey
curves are a sample from the posterior
distribution of the prevalence curve, and
the red curve is the posterior mode. The
broken lines show the year-specific 95%
confidence intervals for prevalence.
Figure 4 Bayesian melding for
estimating and projecting HIV prevalence
(on the Y-axis) in urban areas of Namibia
(A) based on antenatal clinic data only,
and (B) calibrated to represent prevalence
among the overall urban population. The
coloured lines with symbols show the
raw antenatal clinic prevalence. The light
grey curves are a sample from the
posterior distribution of the prevalence
curve, and the red curve is the posterior
mode. The broken lines show the year-
specific 95% confidence intervals for
prevalence.
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narrower confidence interval for 2007.
The general calibration method for countries without
population-based estimates allows for adjusting biases in
antenatal clinic data compared to population estimates. This
calibration method gives the overall adjustment, based on what
has been observed in several countries. Using this general
calibration method changes the estimates of HIV prevalence,
but has less impact on the width of the confidence intervals, as
illustrated for Namibia. With more population-based surveys
becoming available, fewer countries will need to use the general
calibration method, and country-specific calibrations can be
carried out to get more accurate estimates and predictions of
HIV prevalence.
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